TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,449,652 | -1.5% | 1,903,662 | 0.0% | 5.37% | +33.0% |
| Q2 2023 | $29,906,530 | -4.7% | 1,903,662 | 0.0% | 4.04% | -3.8% |
| Q1 2023 | $31,372,350 | +5.6% | 1,903,662 | 0.0% | 4.20% | -1.2% |
| Q4 2022 | $29,697,127 | +36.1% | 1,903,662 | +13.1% | 4.25% | +61.5% |
| Q3 2022 | $21,827,000 | +21.9% | 1,682,834 | +31.9% | 2.63% | +114.4% |
| Q2 2022 | $17,910,000 | -2.0% | 1,275,656 | 0.0% | 1.23% | +48.0% |
| Q1 2022 | $18,268,000 | +5.1% | 1,275,656 | 0.0% | 0.83% | -20.9% |
| Q4 2021 | $17,387,000 | -21.2% | 1,275,656 | -5.3% | 1.05% | -22.5% |
| Q3 2021 | $22,062,000 | -2.7% | 1,346,933 | 0.0% | 1.35% | +9.5% |
| Q2 2021 | $22,669,000 | +110.6% | 1,346,933 | +128.5% | 1.24% | +60.7% |
| Q1 2021 | $10,762,000 | -59.0% | 589,390 | -59.2% | 0.77% | -56.3% |
| Q4 2020 | $26,264,000 | +125.2% | 1,443,052 | +120.8% | 1.76% | +64.4% |
| Q3 2020 | $11,662,000 | -0.5% | 653,662 | 0.0% | 1.07% | -31.4% |
| Q2 2020 | $11,720,000 | +94.1% | 653,662 | +64.4% | 1.56% | +49.4% |
| Q1 2020 | $6,037,000 | -23.1% | 397,662 | 0.0% | 1.04% | -10.4% |
| Q4 2019 | $7,846,000 | +14.7% | 397,662 | 0.0% | 1.17% | -4.4% |
| Q3 2019 | $6,840,000 | +115.9% | 397,662 | +122.2% | 1.22% | +165.2% |
| Q2 2019 | $3,168,000 | +111.2% | 178,962 | +143.0% | 0.46% | +146.0% |
| Q1 2019 | $1,500,000 | – | 73,661 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |